Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC

• Main Authors: Wan Ling Tan, Kevin L.M. Chua, Chia Chi Lin, Victor H.F. Lee, Lye Mun Tho, Anthony W. Chan, Gwo Fuang Ho, Thanyanan Reungwetwattana, James C. Yang, Dong Wan Kim, Ross A. Soo, Yong Chan Ahn, Hiroshi Onishi, Myung Ju Ahn, Tony S.K. Mok, Daniel S.W. Tan, Fan Yang
• Other Authors: Peking University People's Hospital
• Format: Review
• Published: 2020
• Subjects: Medicine
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/53744
• Institution: Mahidol University

© 2019 Stage III NSCLC represents a heterogeneous disease for which optimal treatment continues to pose a clinical challenge. Recent changes in the American Joint Commission on Cancer staging to the eighth edition has led to a shift in TNM stage grouping and redefined the subcategories (IIIA–C) in s...